Invajo - Events tool Create event for free
Place
VGR Campus Nya Varvet (conference room Havsörnen)
Date
September 6 - 7, 2018
Time
09:00 - 13:00

Program

The meeting will start at 09:00 on 6 September, and end at 13:00 on 7 September.

It is a great pleasure for us to announce some of the confirmed speakers who will share with you strong innovation projects arising from excellent Swedish neuroscience research and addressing common neurological conditions in desperate need for effective therapy. In addition to interesting presentations, this event will provide a unique opportunity to meet and network.

Preliminary Program:

Day 1 – September 6th
 

09.00 Arrival at Nya Varvet Göteborg & coffee
09.30 Introduction


09.40-10.50 AD panel – academia, industry, health care
Chair: Gunilla Osswald, CEO at BioArtic AB
Medical need and innovation landscape
·       Kaj Blennow, GU (20 min): Swedish research on CSF biomarkers - from early developments to the basis for the biological definition of Alzheimer’s Disease
Short presentation of innovation projects
·       Per Wester- Alzinova (15 min): Active immunotherapy - A new innovation in Alzheimer's treatment
·       Gunilla Osswald- BioArctic  (15 min): Disease modification treatment for Alzheimer´s disease – in sight!
        -Positive Phase 2b results of BAN2401 in early AD

·       Leslie Pendrill- RISE (15 min): Improved analysis of correlation between cognitive ability and AD biomarkers

 
10.50-11.20 Coffee


11.20-12.10 AD panel continued
·       Short presentation of innovation projects
·       Petronella Kettunen, GU (10 min): The zebrafish as an emerging model for drug discovery in CNS disease
·       Samuel Svensson, CBD Solutions (10 min): Development of selective TAU PET tracers for neuroimaging in 4R-tauopathies
Discussion panel- Innovations for new approaches in AD

 
12.10-13.30 Lunch


13.30-16.00 Stroke panel – academia, industry, health care
Chairs: Wieloch, Pekna, Pekny
·       Medical needs and innovation projects:
·       Tadeusz Wieloch, LU and Sinntaxis AB: mGluR5 as novel pharmacological target for stroke recovery
·       Marcela Pekna, GU: The complement system - experimental therapy to promote stroke recovery
·       Milos Pekny, GU: Astrocytes, a novel therapeutic target in neurodegeneration
·       Karsten Ruscher, LU: Receptor mediated plasticity by triiodothyronine in stroke
·       Mikael Persson, Chalmers: Portable diagnostics for ambulances


Discussion panel – Innovations for new approaches in stroke
(Wieloch, LU & Sinntaxis; Hicks, AstraZeneca; Pekny, GU; Pekna, GU)

16.00-16.20 Coffee


16.20-17.00

Åsa Wallin, Swelife: Innovation and collaboration in Life Science – from ideas to societal benefits
Mikael von und zu Fraunberg, Neurocenter Finland: Neurocenter Finland - promoting neuroscience and innovation
Erik Portelius, Alzheimer Sverige

TBD


 
17.30 Get-together

18.00 Dinner


Day 2  - September 7th


09.00-09.50 PD panel – academia, industry, health care
Unmet medical needs and ongoing clinical trials
·       Per Svenningsson, KI (20 min)  

Short presentation of innovation projects
·       Christer Möller, BioArctic (15 min): Disease modification treatment for Parkinson´s disease – in progress!
·       Nicholas Waters, IRLAB (15 min): IRL790 and IRL752 – two phase II programs addressing medical needs in PD

09.50-10.20 Coffee


10.20-11.20 PD panel continued
Short presentation of innovation projects
·       Angela Cenci Nilsson, LU (10 min): An experimental platform to evaluate potential disease-modifying treatments for Parkinson’s disease
·       Francesco Bez, Redoxis (10 min): Flow cytometric microglia detection in PD models

·       Jeanette Hällgren Kotaleski, KTH & HBP (10 min): Multiscale modeling and simulations as tools to interpret efficacy data in PD and other CNS disorders
Discussion panel – innovations for better treatments in PD

11:20-11.40 Break


11:40-12.40

Panel discussion: How to ensure that innovative ideas and projects are supported by adequate resources and expertise to reach the market and make impact on the society

Chair: Tadeusz Wieloch

Miia Kivipelto:
summarises the meeting and sets the stage
Mikael von und zu Fraunberg,
Finland Neuroscience Center
Magnus Björsne,
AstraZeneca BioVentureHub
Mats Ferm, KI Innovation AB

 


12.40-13.00 BrainGain Tass and the Road Ahead


13.00 End of meeting
 
Program Committee: Kina Höglund (GU), Peder Svensson (IRL), Milos Pekny (GU), Marcela Pekna (GU), Tadeusz Wieloch (LU)